Correlation Between Xvivo Perfusion and Mycronic Publ

Can any of the company-specific risk be diversified away by investing in both Xvivo Perfusion and Mycronic Publ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xvivo Perfusion and Mycronic Publ into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xvivo Perfusion AB and Mycronic publ AB, you can compare the effects of market volatilities on Xvivo Perfusion and Mycronic Publ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xvivo Perfusion with a short position of Mycronic Publ. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xvivo Perfusion and Mycronic Publ.

Diversification Opportunities for Xvivo Perfusion and Mycronic Publ

-0.56

Correlation Coefficient

Xvivo Perfusion  Mycronic Publ

Excellent diversification

The 3 months correlation between Xvivo and Mycronic is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Xvivo Perfusion AB and Mycronic publ AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mycronic publ AB and Xvivo Perfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xvivo Perfusion AB are associated (or correlated) with Mycronic Publ. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mycronic publ AB has no effect on the direction of Xvivo Perfusion i.e., Xvivo Perfusion and Mycronic Publ go up and down completely randomly.

Pair Corralation between Xvivo Perfusion and Mycronic Publ

Assuming the 90 days trading horizon Xvivo Perfusion AB is expected to under-perform the Mycronic Publ. But the stock apears to be less risky and, when comparing its historical volatility, Xvivo Perfusion AB is 1.1 times less risky than Mycronic Publ. The stock trades about -0.06 of its potential returns per unit of risk. The Mycronic publ AB is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  38,000  in Mycronic publ AB on September 12, 2024 and sell it today you would earn a total of  3,200  from holding Mycronic publ AB or generate 8.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Xvivo Perfusion AB  vs.  Mycronic publ AB

Xvivo Perfusion AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Mycronic publ AB

Risk-Adjusted Performance

5 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mycronic publ AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Mycronic Publ may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Xvivo Perfusion and Mycronic Publ

The main advantage of trading using opposite Xvivo Perfusion and Mycronic Publ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xvivo Perfusion position performs unexpectedly, Mycronic Publ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mycronic Publ will offset losses from the drop in Mycronic Publ's long position.

The idea behind Xvivo Perfusion AB and Mycronic publ AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.